Search by Drug Name or NDC

    NDC 49873-0404-01 Sankaijo 8.33; 1.36 mg/1; mg/1 Details

    Sankaijo 8.33; 1.36 mg/1; mg/1

    Sankaijo is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Sato Pharmaceutical Co., Ltd.. The primary component is DOCUSATE SODIUM; SENNOSIDES.

    Product Information

    NDC 49873-0404
    Product ID 49873-404_0b54b2d1-83e7-3a18-e063-6394a90a5b58
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Sankaijo
    Proprietary Name Suffix n/a
    Non-Proprietary Name docusate sodium, sennosides
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 8.33; 1.36
    Active Ingredient Units mg/1; mg/1
    Substance Name DOCUSATE SODIUM; SENNOSIDES
    Labeler Name Sato Pharmaceutical Co., Ltd.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M007
    Listing Certified Through 2024-12-31

    Package

    NDC 49873-0404-01 (49873040401)

    NDC Package Code 49873-404-01
    Billing NDC 49873040401
    Package 1 BOTTLE in 1 CARTON (49873-404-01) / 150 TABLET in 1 BOTTLE
    Marketing Start Date 2002-12-20
    NDC Exclude Flag N
    Pricing Information N/A